Patents by Inventor Margaret Garner

Margaret Garner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8795706
    Abstract: Methods of treating ocular diseases using dithiol compounds, their derivatives, and pharmaceutically acceptable salts thereof are disclosed. In particular, methods using dithiol compounds that comprise derivatives of lipoic acid are described. The dithiol compounds are especially useful for treating ocular diseases such as presbyopia and cataract.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: August 5, 2014
    Assignee: Encore Health, LLC
    Inventors: William Garner, Margaret Garner, George Minno, Ronald D. Blum, David Gooden
  • Publication number: 20140121266
    Abstract: Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.
    Type: Application
    Filed: March 27, 2013
    Publication date: May 1, 2014
    Applicant: ENCORE HEALTH LLC
    Inventors: William Garner, Margaret Garner, George Minno, David Gooden
  • Patent number: 8697109
    Abstract: Novel mercaptan compounds, particularly those including a photolabile protecting group, are described as well as methods of using the compounds for the prevention and treatment of ocular damage and disease.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: April 15, 2014
    Assignee: Encore Health, LLC
    Inventors: William Garner, Margaret Garner, Ronald D. Blum
  • Patent number: 8647612
    Abstract: Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.
    Type: Grant
    Filed: February 23, 2009
    Date of Patent: February 11, 2014
    Assignee: Encore Health, LLC
    Inventors: William Garner, Margaret Garner, Ronald D. Blum
  • Patent number: 8410162
    Abstract: Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: April 2, 2013
    Assignee: Encore Health LLC
    Inventors: William Garner, Margaret Garner, George Minno, David Gooden
  • Publication number: 20100317608
    Abstract: Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.
    Type: Application
    Filed: June 15, 2010
    Publication date: December 16, 2010
    Applicant: Encore Health LLC
    Inventors: William Garner, Margaret Garner, George Minno, Ronald D. Blum, David Gooden
  • Publication number: 20100317725
    Abstract: Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.
    Type: Application
    Filed: June 15, 2010
    Publication date: December 16, 2010
    Applicant: Encore Health LLC
    Inventors: William Garner, Margaret Garner, George Minno, Gooden David
  • Publication number: 20090227677
    Abstract: Compositions containing low doses of lipoic acid-based active agents and methods for using the same are provided. In particular, compositions containing low dose lipoic acid, lipoic acid derivatives, and lipoic acid seleno-derivatives and are provided to prevent and/or treat ocular diseases.
    Type: Application
    Filed: November 7, 2008
    Publication date: September 10, 2009
    Applicant: Encore Health, LLC
    Inventors: William Garner, Margaret Garner
  • Publication number: 20090192212
    Abstract: Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.
    Type: Application
    Filed: February 23, 2009
    Publication date: July 30, 2009
    Applicant: Encore Health, LLC
    Inventors: William Garner, Margaret Garner, Ronald D. Blum
  • Publication number: 20090124683
    Abstract: Novel mercaptan compounds, particularly those including a photolabile protecting group, are described as well as methods of using the compounds for the prevention and treatment of ocular damage and disease.
    Type: Application
    Filed: November 7, 2008
    Publication date: May 14, 2009
    Applicant: Encore Health, LLC
    Inventors: William Garner, Margaret Garner, Ronald D. Blum